The morphological classification of gliomas has been integrated with the introduction of genetic markers, such as the IDH1 gene encoding the enzyme, isocitrate dehydrogenase type-1, co-deletion of chromosomes 1p-19q, and deletion of X chromosome [3-5]. This evidence concerns the gene IDH1 and central nervous system cancer.